TTNP
Titan Pharmaceuticals
TTNP
TTNP
Delisted
TTNP was delisted on the 1st of October, 2025.
20 hedge funds and large institutions have $988K invested in Titan Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
26% less call options, than puts
Call options by funds: $741K | Put options by funds: $999K
Holders
20
Holding in Top 10
–
Calls
$741K
Puts
$999K
Top Buyers
| 1 | +$216K | |
| 2 | +$119K | |
| 3 | +$69K | |
| 4 |
Bank of New York Mellon
New York
|
+$54K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$51.9K |
Top Sellers
| 1 | -$11.5K | |
| 2 | -$9.58K | |
| 3 | -$7K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$3.4K |